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Background and PurposezzInterest in gender differences in the effects of acute stroke is grow-
ing worldwide. However, gender differences in functional recovery after acute stroke in the Korean 
population have yet to be evaluated. The aim of this investigation was to compare long-term func-
tional outcomes between male and female after acute stroke.
MethodszzPatients with acute stroke were enrolled prospectively between January 2005 and Jan-
uary 2009. Baseline characteristics, risk factors, stroke subtypes, time delay from onset to arrival at 
a hospital, active treatment, and stroke severity were compared between male and female. Differenc-
es in mortality and disability at discharge, and at 3 months and 1 year after stroke onset were also in-
vestigated. Functional disabilities were categorized into two groups: good outcome (score on modified 
Rankin scale ≤2) and poor outcome (score on modified Rankin scale >2).
ResultszzAmong 1,055 patients with acute stroke, 575 were male (aged 64.83±11.98 years, mean 
±SD) and 480 were female (aged 70.09±13.02 years). There were no gender differences in mortali-
ty at 3 months and 1 year after stroke. The frequency of poor outcomes was higher in female pa-
tients than in male patients at discharge (39.8% versus 30.9%, respectively; p=0.003), the 3 months 
follow-up (32.3% versus 20.8%, respectively; p<0.001), and the 1 year follow-up (31.1% versus 
18.7%, respectively; p=0.001). After adjusting for multiple confounding factors including age and 
stroke severity, the female gender persisted as a predictor of poor functional outcome at 3 months 
and 1 year after stroke.
ConclusionszzFemale patients have greater difficulty than male patients in recovering from a dis-
abled state after acute stroke. Future studies should investigate the causes of this gender difference.
  J Clin Neurol 2010;6:183-188
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Introduction
Stroke is the major cause of adult disability worldwide.
1,2 Al-
though it is known that there are gender differences in various 
factors of stroke, such as risk factors, clinical manifestations, 
mortalities, and functional outcomes, they have received atten-
tion only recently.
3-5 Gender differences in stroke are worthy of 
investigation because female stroke patients-who have a higher 
prevalence of stroke due to a longer life expectancy-will be a great-
er burden to our society than male stroke patients.
6
The few studies that have analyzed gender differences in st-
roke
4,7-9 have produced diverse results, but there are several com-
mon findings: compared with males, females tend to be older 
at stroke onset, have a higher prevalence of atrial fibrillation 
but a lower prevalence of cardiovascular disease,
8,10-13 and are 
less likely to receive acute treatment.
6,14,15 However, the exis-
tence of gender differences in other stroke factors, such as mor-
tality and functional outcome, remains controversial.
7-9,16,17 In 
one European Multicenter Study,
16 female patients exhibited sig-
nificant disabilities and handicaps at the 3 months poststroke 
follow-up, whereas 3 months survival was the same in males and 
females. In the Framingham Heart Study,
17 34% of the women 
were disabled at 6 months poststroke, compared with only 16% 
of the men. According to the results of the Registry of the Ca-
nadian Stroke Network,
8 women were more likely than men to 
be discharged to long-term care and had greater disabilities at 
6 months poststroke. However, mortality and quality of life at 
6 months poststroke were similar in males and females.
There are currently no long-term follow-up studies of func-Gender Differences in Recovery after Stroke
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tional outcomes after stroke in Korea. The aim of the present 
study was thus to compare the long-term functional outcomes 
between male and female patients with acute stroke in a single 
hospital-based stroke registry.
Methods
Between January 2005 and January 2009, 1,055 consecutive pa-
tients with acute stroke (i.e., within 7 days after symptom on-
set) were identified at Soonchunhyang University Hospital. We 
separated patients according to gender and prospectively ana-
lyzed their baseline characteristics, mortality, and functional 
outcomes at discharge and at 3 months and 1 year after stroke 
onset. We compared the mean age, time delay from symptom 
onset to hospital arrival, and risk factors between the genders. 
The risk factors included past history of hypertension (previous 
diagnosis, current treatment, or blood pressures of ≥160/95 
mmHg in at least two subsequent measurements), diabetes mel-
litus (previous diagnosis or current treatment with insulin or 
oral hypoglycemic medications, or a fasting plasma glucose 
level of ≥126 mg/dL in at least two subsequent measurements), 
hyperlipidemia (diagnosis or current treatment with lipid-low-
ering agents, or serum low-density lipoprotein concentration of 
≥160 mg/dL), smoking (currently or previously), and potential 
cardioembolic source. 
The existences of previous transient ischemic attack (acute 
neurological deficit of vascular origin, lasting <24 hours) and 
stroke (including ischemic or hemorrhagic stroke) were also 
analyzed. We also investigated compliance with medication for 
risk factors in those patients with at least one more risk factors. 
Stroke subtype was classified according to the Trial of Org 
10,172 in Acute Stroke Treatment criteria.
18
We analyzed various variables at admission and discharge. 
At admission, gender differences  were assessed in stroke se-
verity according to the National Institutes of Health Stroke Sc-
ale (NIHSS), and in the use of intravenous recombinant tissue 
plasminogen activator (rt-PA). At discharge, the duration of hos-
pital stay, achievement of anticoagulation for high-risk patients 
of cardioembolic source, stroke severity, functional outcome 
on the modified Rankin scale (mRS), and mortality during hos-
pitalization were analyzed. The initial neurologic deficits were 
categorized using the NIHSS into mild (score ≤7), moderate 
(score >7 and ≤16), and severe (score >16).
Functional outcome as determined by mRS score and mor-
tality were followed up at 3 months and 1 year after stroke on-
set in the available survivors. The mRS scores were dichoto-
mized into ≤2 (good functional outcome) and >2 (poor out-
come). These assessments were made via telephone or face-to-
face interview at outpatient clinic.
Univariate and multivariate analyses were performed with 
SPSS version 15.0 for Windows (SPSS Inc, Chicago, IL, USA). 
Univariate analysis was performed using the χ
2 test for dichot-
omous variables and the t-test for continuous variables. The 
level of statistical significance was set at p<0.05. Multivariate 
analysis was carried out with a logistic regression model. Vari-
ables with a probability of p<0.1 in univariate analysis were 
included in the multivariate analysis. The results of the logistic 
regressions are presented using 95% confidence intervals (CIs). 
Other data are presented as mean±SD values except where 
stated otherwise.
Results
Among 1,055 patients, 480 (45.4%) were female. Baseline vari-
ables stratified according to gender are summarized in Table 1. 
The females (aged 70.09±13.02 years) were significantly older 
than the males (aged 64.83±11.98 years). Females exhibited a 
significantly higher prevalence of hyperlipidemia than males 
(22.5% versus 16.1%, respectively; p=0.008) and a lower pre-
valence of smoking (6.8% versus 46.9%, respectively; p< 
0.001). No differences were found for prevalence of previous 
transient ischemic attack, stroke, hypertension, diabetes, and 
cardioembolic source. Female patients appeared to comply bet-
ter with medication for risk factors than did male patients, but 
the difference was statistically insignificant (87.6% versus 82.3%, 
respectively; p=0.052). Among the subtypes of stroke, the prev-
alence of small-vessel occlusion was significantly lower in fe-
males than in males (14% versus 19.8%, respectively; p=0.013). 
There were no significant differences in the time from symptom 
onset to arrival at the hospital, use of intravenous rt-PA, and an-
ticoagulation for high-risk patients of cardioembolic source. St-
roke severities according to NIHSS score at admission (5.72± 
6.34 versus 5.12±5.82, respectively; p=0.024) and discharge 
(5.43±9.06 versus 4.49±7.88, respectively; p= 0.005) were sig-
nificantly higher in females than males. The duration of hospital-
ization was significantly longer for females than for males (20.69 
±39.78 versus 16.91±25.89 days, respectively; p=0.04). The in-
hospital mortality rate (5.6% versus 3.1%; p=0.046) was signifi-
cantly higher in females than in males, but there was no difference 
in mortality at 3 months (2% versus 1.4%, respectively; p=0.507) 
and 1 year (4.4% versus 2.5%, respectively; p=0.227) after stroke 
onset.
Gender differences in functional outcome for survivors dur-
ing hospitalization, at discharge, and at 3 months and 1 year af-
ter stroke onset are presented in Table 2. The 20 patients who 
died while hospitalized and the 58 patients within 3 months from 
stroke onset were excluded at 3 months analysis. The 13 patients 
who died during the 3 months follow-up period and the 189 pa-
tients within 1 year from stroke onset were excluded at 1 year 
analysis. The mRS score was thus checked in 775 patients Kim JS et al.
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(77.73%) at 3 months and in 566 patients (71.19%) at 1 year po-
ststroke. Data on the premorbid functional status were only 
available for 468 patients (44.36%) after commencement of the 
new Web-based stroke registry (Clinical Research Center for 
Stroke). Premorbid functional status as assessed by mRS was 
worse in females than in males (0.75±1.28 versus 0.67±1.08, 
respectively; p=0.015). The mRS score at discharge was 2.23± 
1.81 in females and 1.95±1.66 in males. Female patients exhib-
ited a higher frequency of poor outcomes than male patients at 
discharge (39.8% versus 30.9%, respectively; p=0.003), and at 3 
months (32.3% versus 20.8%, respectively; p<0.001) and 1 
year (31.1% versus 18.7%, respectively; p=0.001) after stroke 
onset.
In patients with mild neurologic deficits, a poor outcome 
(mRS score >2) was experienced by 28.1%/21.3% (females/
males) at discharge, and by 25.7%/14.5% at 3 months and 
25.2%/13% at 1 year after stroke onset. In the moderate group 
these percentages were 97.8%/95.3%, 87.5%/95.5%, and 87.5%/ 
87.5%, respectively, and in the severe group they were 97.1%/ 
100%, 92.3%/78.6%, and 100%/87.5%, respectively.
The results of multiple logistic regression analysis for pre-
dicting poor functional outcome at 3 months and 1 year after 
acute stroke are presented in Table 3. Among the baseline char-
acters, old age and stroke severity at admission were strongly 
positive predictors of 3 months and 1 year poor functional out-
come. Older age was associated with a greater risk of poor 
Table 1. Differences in baseline characteristics between females and males. Data are mean±SD or n (%) values
Variable Female (n=480) Male (n=575) p
Age (years) 70.09±13.02 64.83±11.98. 0.041*
Risk factors
Previous TIA 14 (2.9%) 17 (3.0%) 0.978
Previous stroke 064 (13.4%) 102 (17.7%) 0.054
Hypertension 300 (62.6%) 346 (60.1%) 0.395
Diabetes mellitus 140 (29.2%) 192 (33.3%) 0.153
Hyperlipidemia 108 (22.5%) ..93 (16.1%) 0.008*
Smoking 30 (6.8%) 270 (46.9%) 0.000*
Cardioembolic source 083 (17.3%) ..79 (13.7%) 0.105
Medication for risk factor 289 (87.6%) 317 (82.3%) 0.052
Stroke subtype
Large-artery atherosclerosis 178 (37.2%) 218 (37.8%) 0.819
Small-vessel occlusion 67 (14%). 114 (19.8%) 0.013*
Cardioembolic infarction ..61 (12.7%) 56 (9.7%) 0.126
Stroke of undetermined etiology
Two episodes or more 32 (6.7%) 28 (4.9%) 0.204
Incomplete ..50 (10.4%) 48 (8.3%) 0.241
Negative 11 (2.3%) 13 (2.3%) 0.966
Stroke of other determined etiology 10 (2.1%) 16 (2.8%) 0.472
TIA 23 (4.8%) 33 (5.7%) 0.503
Hemorrhagic stroke 40 (8.3%) 41 (7.1%) 0.465
Time delay from onset to admission (hours) 34.79±44.45. 35.01±44.55. 0.794
Use of intravenous rt-PA ..32 (29.9%) ..29 (21.0%) 0.110
Severity at admission 0.103
Mild (NIHSS ≤7) 394 (82%)... 501 (87.1%)
Moderate (7<NIHSS≤16) ..49 (10.2%) 44 (7.7%)
Severe (NIHSS>16) 35 (7.3%) 30 (5.2%)
Duration of hospitalization (days) 20.69±39.78. 16.91±25.89. 0.040*
Anticoagulation for high-risk patients of cardioembolic source ..32 (55.2%) 26 (51%). 0.662
Mortality
At discharge 27 (5.6%) 18 (3.1%) 0.046*
From discharge to 3 months  ..7 (2.0%) ..6 (1.4%) 0.507
From 3 months to 1 year  11 (4.4%) ..8 (2.5%) 0.227
*p<0.05.
TIA: transient ischemic attack, NIHSS: National Institutes of Health Stroke Scale, rt-PA: recombinant tissue plasminogen activator.Gender Differences in Recovery after Stroke
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functional outcome at 3 months [66-75 years, odds ratio (OR)= 
1.65, 95% CI=1.03-2.65, p=0.035; 76-85 years, OR=3.04, 95% 
CI=1.80-5.14, p<0.001; >85 years, OR=20.65; 95% CI=7.31-
58.35, p<0.001], and at 1 year after stroke onset (66-75 years, 
OR=1.36; 95% CI=0.77-2.39, p=0.280; 76-85 years, OR=3.30, 
95% CI=1.78-6.10, p<0.001; >85 years, OR=51.36; 95% CI= 
10.33-255.31, p<0.001). More-severe stroke also carried a great-
er risk of poor functional outcome at 3 months (moderate, OR= 
7.72, 95% CI=4.64-12.85, p<0.001; severe, OR=13.35, 95% CI= 
5.67-31.43, p<0.001) and at 1 year (moderate, OR=8.54, 95% 
CI=4.57-15.93, p<0.001; severe, OR=17.08, 95% CI=5.65-51.60, 
p<0.001) after stroke onset. Diabetes (3 months poststroke, OR= 
1.60, 95% CI=1.05-2.45, p=0.028; 1 year poststroke, OR=2.07, 
95% CI=1.26-3.42, p=0.004) and previous history of stroke (3 
months poststroke, OR=2.42, 95% CI= 1.46-4.01, p=0.001; 1 year 
poststroke, OR=2.56, 95% CI= 1.38-4.75, p=0.003) were signifi-
cant predictors of poor functional outcomes at 3 months and 1 
year. In contrast, small-vessel occlusion had a protective effect 
against a 3-month poor functional outcome (OR=0.55, 95% CI= 
0.31-0.99, p=0.047). After adjusting for multiple confounding 
factors, the female gender consistently remained a predictor of 
poor functional outcome at 3 months (OR=1.59, 95% CI=1.02-
2.49, p=0.04) and 1 year (OR=1.74, 95% CI=1.01-2.99, p=0.042) 
after stroke onset.
Discussion
We have demonstrated herein that females are older at stroke 
onset and have a worse functional outcome at 3 months and 1 
year after stroke onset than males, but the mortality rate did not 
differ between the genders. After adjusting for various con-
founding factors including age, stroke severity, and risk factors, 
Table 2. Gender differences in functional outcome after acute stroke. Data are mean±SD or n (%) values
Variable Females Males p
Premorbid mRS score  0.75±1.28 0.67±1.08 0.015*
mRS score at discharge 2.23±1.81 1.95±1.66 0.001*
Good outcome (≤2)  284 (60.2%) 391 (69.1%)
0.003*
Poor outcome (>2)  188 (39.8%) 175 (30.9%)
mRS score at 3 months 1.87±1.52 1.57±1.36 0.001*
Good outcome (≤2)  235 (67.7%) 339 (79.2%)
0.000*
Poor outcome (>2)  112 (32.3%) 089 (20.8%)
mRS score at 1 year 1.81±1.56 1.31±1.32 0.000*
Good outcome (≤2)  173 (68.9%) 256 (81.3%)
0.001*
Poor outcome (>2)  078 (31.1%) 059 (18.7%)
*p<0.05.
mRS: modified Rankin scale. 
Table 3. Multiple logistic regression analysis evaluating predictors of poor functional outcome at 3 months and 1 year after stroke onset
Variable
3 months mRS score
p
1 year mRS score
p
OR 95% CI OR 95% CI
Female 1.59 1.02-2.49 0.040* 1.74 1.01-2.99 0.042*
Age (years)
66-75 1.65 1.03-2.65 0.035* 1.36 0.77-2.39 0.280
76-85 3.04 1.80-5.14 0.000* 3.30 1.78-6.10 0.000*
>85 20.650 07.31-58.35 0.000* 51.360 010.33-255.31 0.000*
Severity
Moderate 7.72 04.64-12.85 0.000* 8.54 04.57-15.93 0.000*
Severe 13.350 05.67-31.43 0.000* 17.080 05.65-51.60 0.000*
Small-vessel occlusion 0.55 0.31-0.99 0.047* 0.49 0.24-1.02 0.057
Previous history of stroke 2.42 1.46-4.01 0.001* 2.56 1.38-4.75 0.003*
Risk factors
Hypertension 0.81 0.53-1.22 0.317.. 0.85 0.52-1.39 0.518
Diabetes mellitus 1.60 1.05-2.45 0.028* 2.07 1.26-3.42 0.004*
Hyperlipidemia 1.30 0.81-2.09 0.271.. 1.06 0.58-1.92 0.845
Cardioembolic source 0.89 0.52-1.53 0.685.. 0.89 0.47-1.71 0.745
*p<0.05.
OR: odds ratio, CI: confidence interval, mRS: modified Rankin scale. Kim JS et al.
www.thejcn.com  187
the female gender persisted as a predictor of poor functional 
outcome at 3 months and 1 year after stroke onset. Our results 
mean that females tend to live longer but with greater disabili-
ty than males following acute stroke.
Previous studies have suggested the occurrence of worse 
functional outcomes among females following stroke, and have 
offered reasons for this finding. One study explained the worse 
functional outcomes in females by a worse preadmission func-
tional status among females, and weaker social support, with 
more women than men being widowed and living alone.
8 In an-
other study,
16 that female gender was a significant predictor of 
disability and handicap was attributed to the balance of medi-
cal and social factors, and women being more frail, making 
them more vulnerable. Our study also revealed a worse func-
tional outcome for females than males for up to 1 year following 
stroke. Considering that no differences between males and fe-
males were found with regard to prior control of risk factors or 
acute management during hospitalization, the worse function-
al outcome of females revealed in the present study suggests that 
Korean women find it more difficult to recover from the disabl-
ed state after discharge.
A census in 2004 conducted by the Korean Ministry of 
Health, Welfare, and Family Affairs
19 found that 66.1% of el-
derly females but only 11.6% of elderly males were unmarried. 
In addition, 29.3% of elderly females but only 6.6% of elderly 
males lived alone. The social status of females in Korea differs 
markedly from their counterparts in Western countries. In East 
Asian societies, including Korea, Confucianism has served as 
the foundation for ethical conduct in socioeconomic and polit-
ical areas of life during the past 500 years.
20 The social activi-
ties of women have been very restricted and their health rela-
tively ignored because of the Confucian understanding of wo-
man, which follows a patriarchal-feudalistic male chauvinism. 
At senescence, women would be unmarried and have no care-
givers, and thus little will to recover. Another possible cause 
of worse functional outcomes in females is their higher preva-
lence of poststroke depression.
9,21-23 In one study,
21 females were 
diagnosed with major depression after stroke twice as frequent-
ly as males. Poststroke depression may delay recovery from the 
disabled state.
Several studies have found that women receive less active tr-
eatment.
7,8,24,25 Other studies
9,24 have found that women have 
little chance of arriving at a treatment center within a 3-hour 
time window to receive thrombolytic therapy, and the use of 
premorbid and at-discharge medication of aspirin and warfa-
rin is lower among women. Although the patients included in 
our study were limited to those admitted to a single hospital and 
involved a relatively small number, there was no difference in 
the treatment modalities applied to the genders. 
Furthermore, there were no differences in time delay from 
stroke onset to arrival at the hospital, use of rt-PA, and the 
rate of anticoagulation for high-risk patients of cardioembol-
ic source.
Gender differences in risk factors and stroke subtypes have 
been reported previously. Some studies found that the preva-
lence of atrial fibrillation and cardioembolic infarction of 
stroke subtypes were higher in female patients than in male 
patients.
10-13 In one large-scale Korean study,
26 hyperlipidemia, 
hypertension, and cardioembolic source were found more fre-
quently in females than in males. However, in our study there 
were no gender differences in cardioembolic source, including 
atrial fibrillation. Instead, female patients exhibited a higher 
prevalence of hyperlipidemia. With regard to stroke subtype, 
small-vessel occlusion was found less frequently in the female 
patients. The differences in distribution of stroke risk factors 
and subtypes might be due to the small sample, regional char-
acteristics, or the restriction of the use of a single hospital-based 
registry.
Various results of stroke mortality rate have been reported. 
Between 1999 and 2004 mortality rate in the USA was higher 
in women than in men at <35 years and >85 years of age; the rate 
was lower in the remaining age group (i.e., 35-84 years).
27 One 
Korean study
26 found that the rate of mortality from any cause 
was higher for women than for men, but after adjusting for con-
founding factors men had the higher death rate because of the 
higher prevalence of cardiovascular disease and due to ethnic 
or racial differences. In our study the rate of death from any cau-
se at discharge was higher for females than for males, and no dif-
ferences were found at the 3 months and 1 year follow-ups. This 
higher rate of mortality at discharge among females might be 
due to their older age and higher severity of stroke symptoms 
on admission.
Our study was subject to some limitations. First, it was a hos-
pital-center-based study rather than a population or multi-
center-based one, and thus the findings cannot be considered 
representative of all Korean stroke patients. Second, prestroke 
mRS data were not available for all of the patients, and so we 
did not include premorbid functional status in the multivariate 
analysis. Finally, there was no information about caregivers, eco-
nomic status, educational level, or familial support after dischar-
ge, all of which can influence functional outcomes.
While the functional outcome at discharge has been inves-
tigated previously, there has been no study of long-term func-
tional outcome after stroke for females in Korea. The findings 
of our study suggest that females find it difficult to recover from 
the poststroke disabled state, which could result in them becom-
ing a greater socioeconomic burden than males. More attention 
should be paid to establishing the causes of this problem, and to 
developing gender-specific management guidelines for female 
Korean stroke patients.Gender Differences in Recovery after Stroke
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